Caveats of using acetaminophen hepatotoxicity models for natural product testing
about
Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis.Protective properties of 2-acetylcyclopentanone in a mouse model of acetaminophen hepatotoxicity.Metabolic phenotyping applied to pre-clinical and clinical studies of acetaminophen metabolism and hepatotoxicity.Natural remedies for non-steroidal anti-inflammatory drug-induced toxicity.Integrated spatiotemporal-metabolic modelling bridges the gap between metabolism on the cellular level and organ function.Connexin hemichannel inhibition reduces acetaminophen-induced liver injury in mice.
P2860
Caveats of using acetaminophen hepatotoxicity models for natural product testing
description
im November 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 04 October 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2012
@uk
name
Caveats of using acetaminophen hepatotoxicity models for natural product testing
@en
Caveats of using acetaminophen hepatotoxicity models for natural product testing
@nl
type
label
Caveats of using acetaminophen hepatotoxicity models for natural product testing
@en
Caveats of using acetaminophen hepatotoxicity models for natural product testing
@nl
prefLabel
Caveats of using acetaminophen hepatotoxicity models for natural product testing
@en
Caveats of using acetaminophen hepatotoxicity models for natural product testing
@nl
P1433
P1476
Caveats of using acetaminophen hepatotoxicity models for natural product testing
@en
P2093
C David Williams
Hartmut Jaeschke
P356
10.1016/J.TOXLET.2012.09.023
P577
2012-10-04T00:00:00Z